Efficacy of risperidone, olanzapine and clozapine in the treatment of therapy resistant schizophrenia

Autor: CJ Slooff, J Arends, M Wardenier

Publikováno v: Acta Neuropsychiatrica, 12(4), 183-192. Cambridge University Press

SUMMARYTherapy-resistance for positive symptoms is one of the most important problems that occurs with the medical treatment of schizophrenia. In the past years, clozapine has proven its effectiveness in this area and has been included in the treatme

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e3846c830319835d22a62fe4783fd10
https://research.rug.nl/en/publications/344f9a7a-0da5-410e-a6fb-350c26b81fdc

[Prevention and treatment of somatic complications arising from the use of antipsychotics]

Autor: Cahn W, Ramlal D, Richard Bruggeman, de Haan L, Fe, Scheepers, Mm, Soest, Assies J, Cj, Slooff

Publikováno v: Europe PubMed Central

Antipsychotics are effective drugs that are prescribed frequently for a large group of patients. However, they also have many side-effects which can lead ultimately to serious somatic complications. These complications fall into various categories: m

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::205622a8d667b19a2a9f59963b90f364
http://europepmc.org/abstract/med/18785105

Differential stigmatizing attitudes of healthcare professionals towards psychiatry and patients with mental health problems: something to worry about? A pilot study.

Autor: Gras LM; Lentis Psychiatric Institute, Lentis Research, Hereweg 80, 9725 AG, Groningen, The Netherlands., Swart M, Slooff CJ, van Weeghel J, Knegtering H, Castelein S

Publikováno v: Social psychiatry and psychiatric epidemiology [Soc Psychiatry Psychiatr Epidemiol] 2015 Feb; Vol. 50 (2), pp. 299-306. Date of Electronic Publication: 2014 Aug 15.

A brief version of the Subjects' Response to Antipsychotics questionnaire to evaluate treatment effects.

Autor: Lako IM; Rob Giel Research Center (RGOc), University of Groningen, University Medical Center Groningen, Groningen, The Netherlands; Pharmacotherapy and Pharmaceutical Care, Department of Pharmacy, University of Groningen, The Netherlands. Electronic address: i.m.lako@rug.nl., Bruggeman R; Rob Giel Research Center (RGOc), University of Groningen, University Medical Center Groningen, Groningen, The Netherlands; University Center of Psychiatry, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands. Electronic address: r.bruggeman@umcg.nl., Liemburg EJ; Rob Giel Research Center (RGOc), University of Groningen, University Medical Center Groningen, Groningen, The Netherlands; Neuroimaging Center, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands. Electronic address: e.j.liemburg@umcg.nl., van den Heuvel ER; Department of Epidemiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands. Electronic address: e.r.van.den.heuvel@umcg.nl., Knegtering H; Rob Giel Research Center (RGOc), University of Groningen, University Medical Center Groningen, Groningen, The Netherlands; Neuroimaging Center, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands; Lentis Center for Mental Health Care, Groningen, The Netherlands. Electronic address: h.knegtering@lentis.nl., Slooff CJ; Rob Giel Research Center (RGOc), University of Groningen, University Medical Center Groningen, Groningen, The Netherlands; Department of Psychotic Disorders, Mental Health Centre Assen (GGZ Drenthe), Assen, The Netherlands. Electronic address: cees.slooff@ggzdrenthe.nl., Wiersma D; Rob Giel Research Center (RGOc), University of Groningen, University Medical Center Groningen, Groningen, The Netherlands. Electronic address: d.wiersma@umcg.nl., Taxis K; Pharmacotherapy and Pharmaceutical Care, Department of Pharmacy, University of Groningen, The Netherlands. Electronic address: k.taxis@rug.nl.

Publikováno v: Schizophrenia research [Schizophr Res] 2013 Jun; Vol. 147 (1), pp. 175-180. Date of Electronic Publication: 2013 Apr 02.

A systematic review of instruments to measure depressive symptoms in patients with schizophrenia.

Autor: Lako IM; Rob Giel Research Center (RGOc), Department of Psychiatry (UCP), University Medical Center Groningen (UMCG), University of Groningen, Hanzeplein 1, 9700 RB, Groningen, The Netherlands. i.m.lako@umcg.nl, Bruggeman R, Knegtering H, Wiersma D, Schoevers RA, Slooff CJ, Taxis K

Publikováno v: Journal of affective disorders [J Affect Disord] 2012 Sep; Vol. 140 (1), pp. 38-47. Date of Electronic Publication: 2011 Nov 17.